The Board of Vincent Medical Holdings Limited announced that the Supply Agreement dated 4 September 2019 was entered into between VMHK and Vyaire, pursuant to which VMHK shall supply the Products to Vyaire in accordance with the agreed specifications and Vyaire shall purchase the Products from VMHK in such amounts as Vyaire may order from time to time during the term of the Supply Agreement for Vyaire's use and/or for resale, directly or indirectly, to the customers of Vyaire. The Supply Agreement is valid for a term of five years commencing from 4 September 2019 to 3 September 2024. VMHK will manufacture the Products exclusively for Vyaire at a Vyaire approved facility; by the delivery dates established in accordance with the Supply Agreement; and in strict compliance with (a) all applicable laws, regulatory requirements and standards and the manufacturing, quality assurance, labeling and packaging specifications for the Products as listed on the Supply Agreement. VMHK will sell the Products to Vyaire, which include all governmental excises, sales and similar assessments, taxes and charges and any duties or other custom charges that are required to be paid. The Supply Agreement will be terminated upon provision of 90 days written notice by Vyaire to the Company. Vyaire is the Group's second largest customer in terms of revenue contribution for the year ended 31 December 2018. In view of the Group's long-term business relationship with Vyaire and given that the manufacture and supply of the Products under the Supply Agreement is an integral part of the business of the Group, the Directors consider that the Supply Agreement will enable the Group to strengthen the business relationship with Vyaire. The Board is of the view that the Supply Agreement is entered into in the ordinary and usual course of business of the Group, on normal commercial terms, and the terms are fair and reasonable and in the interests of the Company and the Shareholders as a whole.